Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Infectious agent antigen detection by immunofluorescent technique; Treponema pallidum

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 87285 refers to a specific laboratory test that detects the presence of the infectious agent Treponema pallidum, which is the bacterium responsible for causing syphilis. This test employs an immunofluorescent technique, a method that utilizes fluorescently labeled antibodies to identify the antigen associated with T. pallidum in a specimen. Syphilis is classified as a sexually transmitted disease (STD) and can have serious health implications if left untreated. The test is particularly significant in diagnosing primary syphilis, where a characteristic sore known as a chancre forms at the site of infection. In certain cases, such as when congenital syphilis is suspected, tissue samples from the umbilical cord may also be analyzed. The importance of this test is underscored by the potential consequences of undiagnosed syphilis during pregnancy, which can lead to severe outcomes for the infant, including stillbirth or immediate postnatal death. Additionally, untreated infants may face long-term developmental challenges. The immunofluorescent antigen detection process involves scraping the suspicious lesion to collect a specimen, followed by the application of a specific reagent that binds to the T. pallidum antigen. After incubation, the specimen is examined under a fluorescence microscope, where positive results are indicated by the appearance of bright green or orange-yellow fluorescence, signifying successful antigen-antibody binding.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The test coded as CPT® 87285 is indicated for the detection of Treponema pallidum in various clinical scenarios, particularly when there is a suspicion of syphilis. The following conditions warrant the performance of this test:

  • Primary Syphilis The test is performed when a patient presents with a chancre, which is a sore that appears at the site of infection, indicating the primary stage of syphilis.
  • Congenital Syphilis In cases where there is concern about congenital syphilis, tissue from the umbilical cord may be tested to determine if the infection has been transmitted from the mother to the fetus.

2. Procedure

The procedure for performing the test under CPT® 87285 involves several critical steps to ensure accurate detection of the T. pallidum antigen. The following outlines the procedural steps:

  • Specimen Collection A specimen is obtained by scraping the suspicious lesion, typically a chancre, to collect cells or tissue that may contain the T. pallidum antigen.
  • Reagent Application A reagent specific for T. pallidum is applied to the collected specimen. This reagent contains antibodies that will bind to the T. pallidum antigen if present.
  • Incubation The specimen is then incubated for a period of 15 to 30 minutes at body temperature in a humid environment. This incubation period allows sufficient time for the antigen-antibody reaction to occur.
  • Washing After incubation, the specimen is washed to remove any unbound conjugate, ensuring that only the bound antigen-antibody complexes remain.
  • Drying and Mounting The specimen is then dried and mounted on a slide, preparing it for microscopic examination.
  • Microscopic Examination A fluorescence microscope, equipped with the appropriate fluorescent light source and barrier filters, is used to examine the specimen. The presence of antigen-antibody binding is indicated by bright green or orange-yellow fluorescence, which confirms a positive test result.

3. Post-Procedure

Post-procedure care for patients undergoing the test coded as CPT® 87285 typically involves no specific requirements, as the test is minimally invasive and does not necessitate recovery time. However, it is essential for healthcare providers to communicate the results to the patient promptly. If the test result is positive, further evaluation and treatment for syphilis should be initiated, including counseling on the implications of the diagnosis and potential treatment options. Additionally, if congenital syphilis is suspected, appropriate follow-up care for the infant should be arranged to address any potential health issues arising from the infection.

Short Descr TREPONEMA PALLIDUM AG IF
Medium Descr IAADI TREPONEMA PALLIDUM
Long Descr Infectious agent antigen detection by immunofluorescent technique; Treponema pallidum
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
Date
Action
Notes
2011-01-01 Changed Short description changed.
2001-01-01 Changed Code description changed.
1998-01-01 Added First appearance in code book in 1998.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"